Suchergebnisse - "Hypoglycemic Agents therapeutic use"

Individual, Social and Environmental Factors Influencing Medication-Taking Among Adults of Vietnamese Heritage With Type 2 Diabetes Living in Australia: A Qualitative Study: A Qualitative Study

Autoren: Omonaiye, Olumuyiwa Holmes-Truscott, Elizabeth Rasmussen, Bodil et al.

Quelle: Omonaiye, O, Holmes-Truscott, E, Rasmussen, B, Hamblin, P S, Mc Namara, K, Tran, J, Steele, C, Lai, J & Manias, E 2025, ' Individual, Social and Environmental Factors Influencing Medication-Taking Among Adults of Vietnamese Heritage With Type 2 Diabetes Living in Australia : A Qualitative Study ', Clinical Therapeutics, vol. 47, no. 5, pp. e1-e11 . https://doi.org/10.1016/j.clinthera.2025.01.012

Schlagwörter: Male, Adult, Medication-taking, Australia/epidemiology, Southeast Asian People, Hypoglycemic Agents/therapeutic use, Type 2 diabetes, Vietnamese, Middle Aged, Focus Groups, Theoretical domains framework, Interviews as Topic, Medication therapy management, Type 2/drug therapy, Medication Adherence/ethnology, Diabetes Mellitus, Humans, Female, Qualitative Research, Vietnam/ethnology, Aged, Ethnic minority groups

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39986967
https://curis.ku.dk/ws/files/448467384/1-s2.0-S014929182500013X-main.pdf

The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)

Autoren: Othmar Moser Dessi P. Zaharieva Peter Adolfsson et al.

Weitere Verfasser: Othmar Moser Dessi P. Zaharieva Peter Adolfsson et al.

Quelle: Diabetologia
Moser, O, Zaharieva, D P, Adolfsson, P, Battelino, T, Bracken, R M, Buckingham, B A, Danne, T, Davis, E A, Dovč, K, Forlenza, G P, Gillard, P, Hofer, S E, Hovorka, R, Jacobs, P G, Mader, J K, Mathieu, C, Nørgaard, K, Oliver, N S, O’Neal, D N, Pemberton, J, Rabasa-Lhoret, R, Sherr, J L, Sourij, H, Tauschmann, M, Yardley, J E & Riddell, M C 2025, ' The use of automated insulin delivery around physical activity and exercise in type 1 diabetes : a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) ', Diabetologia, vol. 68, no. 2, pp. 255–280 . https://doi.org/10.1007/s00125-024-06308-z

Schlagwörter: Blood Glucose, Adult, Adolescent, INTENSITY INTERVAL EXERCISE, CHILDREN, Position statement, Pediatrics, 1117 Public Health and Health Services, Insulin/administration, Adolescent [MeSH], Europe [MeSH], Diabetes Mellitus, Type 1/drug therapy [MeSH], Insulin Infusion Systems [MeSH], Adult [MeSH], Humans [MeSH], Glucose, Insulin pump, Type 1 diabetes, Insulin/therapeutic use [MeSH], Exercise/physiology [MeSH], Exercise, Automated insulin delivery, Physical activity, Blood Glucose/metabolism [MeSH], CGM, Hypoglycemic Agents/therapeutic use [MeSH], Position Statement, Diabetes Mellitus, Type 1/therapy [MeSH], Child [MeSH], Diabetes Mellitus, Type 1/blood [MeSH], Hypoglycemic Agents/administration, Endocrinology & Metabolism, HYPOGLYCEMIA, 03 medical and health sciences, BIONIC PANCREAS, Insulin Infusion Systems, 0302 clinical medicine, GLYCEMIC CONTROL, Humans, Insulin, Hypoglycemic Agents, Child, Continuous glucose monitoring, GLUCOSE CONTROL, Science & Technology, PUMP THERAPY, 3215 Reproductive medicine, 3202 Clinical sciences, 1103 Clinical Sciences, ADULTS, 3213 Paediatrics, Europe, 4206 Public health, Diabetes Mellitus, Type 1, 1114 Paediatrics and Reproductive Medicine, MODERATE-INTENSITY, Life Sciences & Biomedicine

Dateibeschreibung: application/pdf; text/xml; application/zip

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39657609
https://pubmed.ncbi.nlm.nih.gov/39653802
https://lirias.kuleuven.be/handle/20.500.12942/760837
https://doi.org/10.1007/s00125-024-06308-z
https://lirias.kuleuven.be/handle/20.500.12942/755912
https://doi.org/10.1159/000542287
https://curis.ku.dk/ws/files/445105907/s00125-024-06308-z.pdf
https://repository.publisso.de/resource/frl:6494670
https://www.repository.cam.ac.uk/handle/1810/378489
https://doi.org/10.1159/000542287
https://www.repository.cam.ac.uk/handle/1810/378488
https://doi.org/10.1007/s00125-024-06308-z
https://www.repository.cam.ac.uk/handle/1810/378707
https://doi.org/10.1007/s00125-024-06308-z

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants: a pooled analysis of 1108 population-representative studies with 141 million participants

Autoren: NCD Risk Factor Collaboration (NCD-RisC) Bin Zhou Archie W Rayner et al.

Weitere Verfasser: NCD Risk Factor Collaboration (NCD-RisC) Bin Zhou Archie W Rayner et al.

Quelle: Lancet
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
The Lancet, Vol. 404, no. 10467, p. 2077-2093 (2024)
LANCET
The Lancet
NCD Risk Factor Collaboration (NCD-RisC) 2024, 'Worldwide trends in diabetes prevalence and treatment from 1990 to 2022 : a pooled analysis of 1108 population-representative studies with 141 million participants', Lancet, vol. 404, no. 10467, pp. 2077-2093. https://doi.org/10.1016/S0140-6736(24)02317-1

Schlagwörter: Male, Blood Glucose, [SDV]Life Sciences [q-bio], Bayesian statistical decision theory, Diabetes, epidemiology, Global Health, MELLITUS, World health -- Social aspects, Prevalence, DIABETE, PLASMA-GLUCOSE, GLOBAL EPIDEMIC, diabetes, Diabetes, Middle Aged, Health surveys -- Statistical methods, [SDV] Life Sciences [q-bio], Mathematics and Statistics, CARDIOVASCULAR-DISEASE, LIFE-STYLE INTERVENTION, SDG 3 – Gesundheit und Wohlergehen, Endokrinologi och diabetes, Diabetes Mellitus/epidemiology, epidemiology, Female, HEALTH, trends, Adult, diabetes, trends, diabetes prevalence, diabetes treatment, pooled analysis, Adolescent, prevalence, Hypoglycemic Agents/therapeutic use, Endocrinology and Diabetes, Diabetes -- Epidemiology, Article, Young Adult, IMPAIRED GLUCOSE-TOLERANCE, Diabetes -- Treatment -- Statistics, SDG 3 - Good Health and Well-being, MANAGEMENT, Diabetes Mellitus, 303009 Ernährungswissenschaften, Humans, Hypoglycemic Agents, Sex Distribution, Aged, Glycated Hemoglobin, Bayes Theorem, PREVENTION, Global Health/statistics & numerical data, Treatment, Settore MEDS-05/A - Medicina interna, FOLLOW-UP, 303009 Nutritional sciences

Dateibeschreibung: application/pdf; text

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39549716
http://zaguan.unizar.es/record/161851
https://hdl.handle.net/20.500.14243/542686
https://doi.org/10.1016/ S0140-6736(24)02317-1
https://hdl.handle.net/2078.1/293509
https://hdl.handle.net/10447/664601
https://portal.findresearcher.sdu.dk/da/publications/d3cff688-7674-4dab-9d55-8a985ecf1081
https://doi.org/10.1016/S0140-6736(24)02317-1
https://www.um.edu.mt/library/oar/handle/123456789/129260
https://hdl.handle.net/2158/1402513
https://doi.org/10.1016/s0140-6736(24)02317-1
https://www.sciencedirect.com/science/article/pii/S0140673624023171?via=ihub
http://doi.org/10.1016/s0140-6736(24)02317-1
https://biblio.ugent.be/publication/01JDPB4P1R7CQX0NEN6TNAG3HF
http://hdl.handle.net/1854/LU-01JDPB4P1R7CQX0NEN6TNAG3HF
https://biblio.ugent.be/publication/01JDPB4P1R7CQX0NEN6TNAG3HF/file/01JDPBGTP1DXSZXB740CBA0PYE
https://hdl.handle.net/11250/3180225
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-548742
https://hdl.handle.net/10037/36567
https://hdl.handle.net/11250/3198263

Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes: evaluating Semaglutide in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes

Autoren: Marc P Bonaca Andrei-Mircea Catarig Yasemin Hansen et al.

Quelle: European Heart Journal - Cardiovascular Pharmacotherapy. 10:728-737

Schlagwörter: Male, Glucagon-Like Peptides/adverse effects, Time Factors, Intermittent Claudication/drug therapy, Hypoglycemic Agents/therapeutic use, Walk Test, Europe/epidemiology, Injections, Blood Glucose/drug effects, Double-Blind Method, Maximal walking distance, Diabetes Mellitus, Humans, Glucagon-Like Peptide-1 Receptor/agonists, Clinical Trials, Peripheral Arterial Disease/drug therapy, Aged, Exercise Tolerance/drug effects, Peripheral artery disease, Subcutaneous, Semaglutide, GLP1 agonist, Recovery of Function, Middle Aged, PAD, Phase III as Topic, Treatment Outcome, Type 2/drug therapy, Incretins/adverse effects, Quality of Life, Female, Biomarkers/blood

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39424598
https://portal.findresearcher.sdu.dk/da/publications/6ed731d3-a98a-4dad-9fd6-e4588abfe90b
https://doi.org/10.1093/ehjcvp/pvae071

Dialysis Nurses’ Experiences with Continuous Glucose Monitoring in Hemodialysis Patients Treated with Insulin

Autoren: Sisse H. Laursen Inger V. Kristensen Hanne R. Larsen et al.

Quelle: Studies in Health Technology and Informatics ISBN: 9781643685908
Laursen, S H, Kristensen, I V, Larsen, H R, Vestergaard, P, Jensen, M H & Hejlesen, O K 2025, Dialysis Nurses' Experiences with Continuous Glucose Monitoring in Hemodialysis Patients Treated with Insulin. in Envisioning the Future of Health Informatics and Digital Health. vol. 323, IOS Press, Studies in health technology and informatics, vol. 323, pp. 317-321, The 22nd International Conference on Informatics, Management, and Technology in Healthcare, 13/12/2024. https://doi.org/10.3233/SHTI250103

Schlagwörter: Blood Glucose, Male, hemodialysis patients, Attitude of Health Personnel, Blood Glucose Self-Monitoring, insulin-treated diabetes, nursing perspective, Hypoglycemic Agents/therapeutic use, Renal Dialysis/nursing, Blood Glucose Self-Monitoring/nursing, Blood Glucose/analysis, Middle Aged, Renal Dialysis, Insulin/therapeutic use, Diabetes Mellitus, Continuous Glucose Monitoring, Humans, Insulin, Hypoglycemic Agents, Female, Continuous glucose monitoring, Diabetes Mellitus/nursing

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40200500
https://vbn.aau.dk/ws/files/775467056/SHTI-323-SHTI250103.pdf
http://www.scopus.com/inward/record.url?scp=105003111130&partnerID=8YFLogxK
https://doi.org/10.3233/SHTI250103
https://vbn.aau.dk/da/publications/4e7fa799-9006-4db4-bcde-0382b51a4613

Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose‐lowering therapies

Autoren: Anton Pottegård Jacob H. Andersen Jens Søndergaard et al.

Quelle: Pottegård, A, Andersen, J H, Søndergaard, J, Rasmussen, L, Kildegaard, H, Vilsbøll, T & Thomsen, R W 2024, ' Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose-lowering therapies ', Diabetes, Obesity and Metabolism, vol. 26, no. 11, pp. 4996-5004 . https://doi.org/10.1111/dom.15912
Pottegård, A, Andersen, J H, Søndergaard, J, Rasmussen, L, Kildegaard, H, Vilsbøll, T & Thomsen, R W 2024, 'Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose-lowering therapies', Diabetes, Obesity and Metabolism, vol. 26, no. 11, pp. 4996-5004. https://doi.org/10.1111/dom.15912

Schlagwörter: Male, Blood Glucose, Adult, Denmark, Hypoglycemic Agents/therapeutic use, pharmaco-epidemiology, Blood Glucose/drug effects, Diabetes Mellitus, Glycated Hemoglobin/analysis, Humans, Hypoglycemic Agents, Insulin, Metformin/therapeutic use, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Registries, Sodium-Glucose Transporter 2 Inhibitors, Aged, antidiabetic drug, Glycated Hemoglobin, database research, Dipeptidyl-Peptidase IV Inhibitors, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Middle Aged, Denmark/epidemiology, Metformin, Type 2/drug therapy, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Insulin/therapeutic use, Female, type 2 diabetes

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39284788
https://curis.ku.dk/ws/files/411843007/Diabetes_Obesity_Metabolism_2024_Potteg_rd_Treatment_trajectories_for_Danish_individuals_with_type_2_diabetes_in_the.pdf
https://pure.au.dk/portal/en/publications/843bdb25-64ff-4500-ab28-b49a90009e91
http://www.scopus.com/inward/record.url?scp=85204178972&partnerID=8YFLogxK
https://doi.org/10.1111/dom.15912

Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study: The Hypo-METRICS Study

Autoren: Divilly, P. Martine-Edith, G. Zaremba, N. et al.

Weitere Verfasser: Divilly, P. Martine-Edith, G. Zaremba, N. et al.

Quelle: Diabetes Care
Diabetes Care, 47, 10, pp. 1769-1777
Divilly, P, Martine-Edith, G, Zaremba, N, Søholm, U, Mahmoudi, Z, Cigler, M, Ali, N, Abbink, E J, Brøsen, J, de Galan, B, Pedersen-Bjergaard, U, Vaag, A A, McCrimmon, R J, Renard, E, Heller, S, Evans, M, Mader, J K, Amiel, S A, Pouwer, F, Choudhary, P & Hypo-RESOLVE Consortium 2024, ' Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes : The Hypo-METRICS Study ', Diabetes Care, vol. 47, no. 10, pp. 1769-1777 . https://doi.org/10.2337/dc23-2332

Schlagwörter: Male, Adult, Blood Glucose, Hypoglycemic Agents/therapeutic use, name=Internal Medicine, Diabetes Mellitus, Humans, Insulin, Hypoglycemic Agents, Internal Medicine - Radboud University Medical Center, Aged, Blood Glucose Self-Monitoring, Geriatrics - Radboud University Medical Center, Blood Glucose/analysis, Middle Aged, 16. Peace & justice, Hypoglycemia, 3. Good health, Diabetes and Metabolism, Diabetes Mellitus, Type 1, name=Advanced and Specialised Nursing, Type 2/drug therapy, Diabetes Mellitus, Type 2, Insulin/therapeutic use, Type 1/drug therapy, Hypoglycemia/blood, Original Article, Female, name=Endocrinology

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39207738
https://cris.maastrichtuniversity.nl/en/publications/7abab252-2782-4f69-95f9-47955dd4fdef
https://doi.org/10.2337/dc23-2332
https://hdl.handle.net/2066/310540
https://repository.ubn.ru.nl//bitstream/handle/2066/310540/310540.pdf
https://curis.ku.dk/ws/files/407326398/dc232332.pdf

Metformin use and risk of myeloproliferative neoplasms: a Danish population–based case-control study: a Danish population-based case-control study

Autoren: Daniel Tuyet Kristensen Andreas Kiesbye Øvlisen Lasse Hjort Kyneb Jakobsen et al.

Quelle: Blood Adv
Kristensen, D T, Øvlisen, A K, Jakobsen, L H, Severinsen, M T, Hannig, L H, Starklint, J, Hilsøe, M H, Vallentin, A P, Brabrand, M, Hasselbalch, H C, El Galaly, T C & Roug, A S 2024, 'Metformin use and risk of myeloproliferative neoplasms-a Danish population-based case-control study', Blood advances, vol. 8, no. 16, pp. 4478-4485. https://doi.org/10.1182/bloodadvances.2023012266
Kristensen, D T, Øvlisen, A K, Jakobsen, L H K, Severinsen, M T, Hannig, L H, Starklint, J, Hilsøe, M H, Vallentin, A P, Brabrand, M, Hasselbalch, H C, El-Galaly, T C & Roug, A S 2024, 'Metformin use and risk of myeloproliferative neoplasms : a Danish population–based case-control study', Blood Advances, vol. 8, no. 16, pp. 4478-4485. https://doi.org/10.1182/bloodadvances.2023012266

Schlagwörter: Male, Adult, Aged, 80 and over, Myeloproliferative Disorders, Clinical Trials and Observations, Denmark, Hypoglycemic Agents/therapeutic use, Middle Aged, Denmark/epidemiology, Metformin, 3. Good health, Myeloproliferative Disorders/epidemiology, Risk Factors, Case-Control Studies, 80 and over, Odds Ratio, Humans, Hypoglycemic Agents, Metformin/therapeutic use, Female, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38758071
https://vbn.aau.dk/da/publications/5c63b5e4-05c0-4f28-a197-d18aaeb3312b
https://vbn.aau.dk/ws/files/741572588/Kristensen_et_al._2024_._Metformin_use_and_risk_of_myeloproliferative_neoplasms_-_a_Danish_population-based_case-control_study.pdf
http://www.scopus.com/inward/record.url?scp=85203008649&partnerID=8YFLogxK
https://doi.org/10.1182/bloodadvances.2023012266
https://portal.findresearcher.sdu.dk/da/publications/e862bba7-645a-49b0-80cc-2b2072fb729c
https://doi.org/10.1182/bloodadvances.2023012266
https://pure.au.dk/portal/en/publications/dd6ae754-693e-41c0-9eb5-6fb20a03a230
http://www.scopus.com/inward/record.url?scp=85203008649&partnerID=8YFLogxK
https://doi.org/10.1182/bloodadvances.2023012266

Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register‐based drug utilization study: A register-based drug utilization study

Autoren: Lotte Rasmussen Jacob Harbo Andersen Øystein Karlstad et al.

Quelle: Diabetes, Obesity and Metabolism. 26:5479-5482

Schlagwörter: antidiabetic drug, Male, Adult, database research, liraglutide, semaglutide, Drug Utilization/statistics & numerical data, Glucagon-Like Peptides/therapeutic use, Denmark, Glucagon-Like Peptides, Hypoglycemic Agents/therapeutic use, Middle Aged, Scandinavian and Nordic Countries, Denmark/epidemiology, Drug Utilization, Scandinavian and Nordic Countries/epidemiology, pharmaco-epidemiology, Type 2/drug therapy, Diabetes Mellitus, Type 2, Diabetes Mellitus, Humans, Hypoglycemic Agents, Female, Registries, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39164856

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial: a prespecified analysis of the SELECT trial

Autoren: Deanfield, John Verma, Subodh Scirica, Benjamin M et al.

Weitere Verfasser: Deanfield, John Verma, Subodh Scirica, Benjamin M et al.

Quelle: The lancet 404(10454), 773-786 (2024). doi:10.1016/S0140-6736(24)01498-3
Deanfield, J, Verma, S, Scirica, B M, Kahn, S E, Emerson, S S, Ryan, D, Lingvay, I, Colhoun, H M, Plutzky, J, Kosiborod, M N, Hovingh, G K, Hardt-Lindberg, S, Frenkel, O, Weeke, P E, Rasmussen, S, Goudev, A, Lang, C C, Urina-Triana, M, Pietilä, M, Lincoff, A M & SELECT Trial Investigators 2024, 'Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure : a prespecified analysis of the SELECT trial', The Lancet, vol. 404, no. 10454, pp. 773-786. https://doi.org/10.1016/S0140-6736(24)01498-3

Schlagwörter: Male, Glucagon-Like Peptide, obesity, Glucagon-Like Peptides/therapeutic use, Injections, Subcutaneous, Glucagon-Like Peptides, Hypoglycemic Agents/therapeutic use, Injections, Double-Blind Method, Cardiovascular Disease, Humans, Hypoglycemic Agents, Subcutaneou, 03.02. Klinikai orvostan, Obesity, name=General Medicine, Cardiovascular Diseases/mortality, Aged, Heart Failure, 2. Zero hunger, semaglutide, Heart Failure/mortality, Hypoglycemic Agent, Subcutaneous, Stroke Volume, Middle Aged, cardiovascular outcome, cardiovascular outcomes, 3. Good health, Treatment Outcome, Cardiovascular Diseases, Stroke Volume/drug effects, Female, Obesity/complications, Human

Dateibeschreibung: application/pdf; text; STAMPA

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39181597
https://hdl.handle.net/11370/f96e7894-b35a-4160-8790-1b4c54cb001d
https://research.rug.nl/en/publications/f96e7894-b35a-4160-8790-1b4c54cb001d
https://doi.org/10.1016/S0140-6736(24)01498-3
https://pure.amsterdamumc.nl/en/publications/6bd935a1-86ab-4143-9134-e8e420a04929
https://doi.org/10.1016/S0140-6736(24)01498-3
https://hdl.handle.net/20.500.11769/643798
https://doi.org/10.1016/S0140-6736(24)01498-3
https://publications.rwth-aachen.de/record/1008026
https://pure.au.dk/portal/en/publications/4a561529-501f-45b4-9f4a-feaf91a7de22
https://doi.org/10.1016/S0140-6736(24)01498-3
http://www.scopus.com/inward/record.url?scp=85201638599&partnerID=8YFLogxK

Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application

Autoren: Martine-Edith, G. Zaremba, N. Divilly, P. et al.

Quelle: Martine-Edith, G, Zaremba, N, Divilly, P, Søholm, U, Broadley, M, Baumann, P M, Mahmoudi, Z, Gomes, M, Ali, N, Abbink, E J, de Galan, B, Brøsen, J, Pedersen-Bjergaard, U, Vaag, A A, McCrimmon, R J, Renard, E, Heller, S, Evans, M, Cigler, M, Mader, J K, Amiel, S A, Speight, J, Pouwer, F & Hypo-RESOLVE Consortium 2024, 'Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application', Diabetes Technology and Therapeutics, vol. 26, no. 8, pp. 566-574. https://doi.org/10.1089/dia.2023.0596
Diabetes Technology & Therapeutics, 26, 8, pp. 566-574
2024, 'Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application', Diabetes Technology and Therapeutics, vol. 26, no. 8, pp. 566-574. https://doi.org/10.1089/dia.2023.0596

Schlagwörter: Adult, Male, Blood Glucose, Hypo-METRICS, Hypoglycemic Agents/therapeutic use, Hypoglycemia/chemically induced, Fitbit, Hypoglycemia symptoms, Hypoglycemia awareness, Diabetes Mellitus, Humans, Hypoglycemic Agents, Insulin, nocturnal hypoglycemia, Internal Medicine - Radboud University Medical Center, Prospective Studies, sleep tracking, Aged, 2. Zero hunger, Blood Glucose Self-Monitoring, Geriatrics - Radboud University Medical Center, Blood Glucose/analysis, Middle Aged, Awareness, 16. Peace & justice, name=Medical Laboratory Technology, Mobile Applications, Hypoglycemia, 3. Good health, Diabetes and Metabolism, Diabetes Mellitus, Type 1, Type 2/drug therapy, Diabetes Mellitus, Type 2, Insulin/therapeutic use, Type 1/drug therapy, continuous glucose monitoring, Female, Smartphone, name=Endocrinology

Dateibeschreibung: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38512385
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/309511
https://doi.org/10.1089/dia.2023.0596
https://cris.maastrichtuniversity.nl/en/publications/991d276b-3d3e-4c9e-8e4c-987b0e22524a
https://doi.org/10.1089/dia.2023.0596
https://research.vumc.nl/en/publications/2162b531-7c29-4e5c-962e-b7e5a92aacd6
https://pure.amsterdamumc.nl/en/publications/29e075ba-f7a9-4ede-aae2-42177c552373
https://doi.org/10.1089/dia.2023.0596
https://repository.ubn.ru.nl//bitstream/handle/2066/309511/309511.pdf
https://hdl.handle.net/2066/309511
https://kclpure.kcl.ac.uk/ws/files/298388583/Martine-Edith_et_al_Symptoms_Authors_Accepted_MS.docx
https://portal.findresearcher.sdu.dk/da/publications/8a57a1e8-b57a-4750-a84d-8859890a60b2
https://doi.org/10.1089/dia.2023.0596

The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app: a prospective observational study using the Hypo-METRICS app

Autoren: Søholm, Uffe Broadley, Melanie Zaremba, Natalie et al.

Weitere Verfasser: Søholm, Uffe Broadley, Melanie Zaremba, Natalie et al.

Quelle: Diabetologia
Søholm, U, Broadley, M, Zaremba, N, Divilly, P, Baumann, P M, Mahmoudi, Z, Martine-Edith, G, Mader, J K, Cigler, M, Brøsen, J M B G, Vaag, A, Heller, S, Pedersen-Bjergaard, U, McCrimmon, R J, Renard, E, Evans, M, de Galan, B, Abbink, E, Amiel, S A, Hendrieckx, C, Speight, J, Choudhary, P & On behalf of the Hypo-RESOLVE Consortium 2024, 'The impact of hypoglycaemia on daily functioning among adults with diabetes : a prospective observational study using the Hypo-METRICS app', Diabetologia, vol. 67, no. 10. https://doi.org/10.1007/s00125-024-06233-1
Diabetologia, 67, 10, pp. 2160-2174
Søholm, U, Broadley, M, Zaremba, N, Divilly, P, Baumann, P M, Mahmoudi, Z, Martine-Edith, G, Mader, J K, Cigler, M, Brøsen, J M B, Vaag, A, Heller, S, Pedersen-Bjergaard, U, McCrimmon, R J, Renard, E, Evans, M, de Galan, B, Abbink, E, Amiel, S A, Hendrieckx, C, Speight, J, Choudhary, P, Pouwer, F & on behalf of the Hypo-RESOLVE consortium 2024, ' The impact of hypoglycaemia on daily functioning among adults with diabetes : a prospective observational study using the Hypo-METRICS app ', Diabetologia, vol. 67, no. 10, pp. 2160-2174 . https://doi.org/10.1007/s00125-024-06233-1

Schlagwörter: Male, Adult, Blood Glucose, Quality of life, Hypoglycemia/psychology, Hypoglycemic Agents/therapeutic use, name=Internal Medicine, Article, Activities of Daily Living, Diabetes Mellitus, Humans, Hypoglycemic Agents, Insulin, Internal Medicine - Radboud University Medical Center, Prospective Studies, Type 2/physiopathology, Ecological momentary assessment, Aged, 2. Zero hunger, Blood Glucose/metabolism, Blood Glucose Self-Monitoring, daily functioning, Type 1/physiopathology, Middle Aged, 16. Peace & justice, Mobile Applications, Hypoglycemia, 3. Good health, Diabetes and Metabolism, Diabetes Mellitus, Type 1, quality of life, Diabetes Mellitus, Type 2, Insulin/therapeutic use, Female, Daily functioning, name=Endocrinology, Hypoglycaemia, hypoglycaemia

Dateibeschreibung: application/pdf; text/xml

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39080044
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/311138
https://cris.maastrichtuniversity.nl/en/publications/64db5adb-5b72-43e0-bc41-7e2317829502
https://doi.org/10.1007/s00125-024-06233-1
https://research.vumc.nl/en/publications/f9ba8e5c-4f1e-4e2f-84ac-72f1df567fca
https://pure.amsterdamumc.nl/en/publications/65f0b407-799d-4bd7-a1e2-5827b1573f01
https://doi.org/10.1007/s00125-024-06233-1
https://repository.ubn.ru.nl//bitstream/handle/2066/311138/311138.pdf
https://hdl.handle.net/2066/311138
https://curis.ku.dk/ws/files/411842076/s00125_024_06233_1.pdf
https://www.repository.cam.ac.uk/handle/1810/367794
https://doi.org/10.1007/s00125-024-06233-1
https://doi.org/10.17863/cam.108248
https://www.repository.cam.ac.uk/handle/1810/374427
https://doi.org/10.1007/s00125-024-06233-1
https://www.repository.cam.ac.uk/handle/1810/376542
https://doi.org/10.1007/s00125-024-06233-1

A Comparison of the Rates of Clock-Based Nocturnal Hypoglycemia and Hypoglycemia While Asleep Among People Living with Diabetes: Findings from the Hypo-METRICS Study: findings from the Hypo-METRICS study

Autoren: Martine-Edith, Gilberte Divilly, Patrick Zaremba, Natalie et al.

Weitere Verfasser: Martine-Edith, Gilberte Divilly, Patrick Zaremba, Natalie et al.

Quelle: Martine-Edith, G, Divilly, P, Zaremba, N, Søholm, U, Broadley, M, Baumann, P M, Mahmoudi, Z, Gomes, M, Ali, N, Abbink, E J, de Galan, B, Brøsen, J, Pedersen-Bjergaard, U, Vaag, A A, McCrimmon, R J, Renard, E, Heller, S, Evans, M, Cigler, M, Mader, J K, Speight, J, Pouwer, F, Amiel, S A & Choudhary, P 2024, 'A Comparison of the Rates of Clock-Based Nocturnal Hypoglycemia and Hypoglycemia While Asleep Among People Living with Diabetes : Findings from the Hypo-METRICS Study', Diabetes Technology and Therapeutics, vol. 26, no. 7, pp. 433-441. https://doi.org/10.1089/dia.2023.0522
Diabetes Technology & Therapeutics, 26, 7, pp. 433-441
Martine-Edith, G, Divilly, P, Zaremba, N, Søholm, U, Broadley, M, Baumann, P M, Mahmoudi, Z, Gomes, M, Ali, N, Abbink, E J, de Galan, B, Brøsen, J, Pedersen-Bjergaard, U, Vaag, A A, McCrimmon, R J, Renard, E, Heller, S, Evans, M, Cigler, M, Mader, J K, Speight, J, Pouwer, F & Amiel, S A & Choudhary, P 2024, 'A Comparison of the Rates of Clock-Based Nocturnal Hypoglycemia and Hypoglycemia While Asleep Among People Living with Diabetes : Findings from the Hypo-METRICS Study', Diabetes Technology and Therapeutics, vol. 26, no. 7, pp. 433-441. https://doi.org/10.1089/dia.2023.0522

Schlagwörter: Male, Blood Glucose, Type 1/blood, Hypo-METRICS, Hypoglycemic Agents/therapeutic use, Fitbit, Sleep/physiology, Diabetes Mellitus, Humans, Hypoglycemic Agents, Insulin, Internal Medicine - Radboud University Medical Center, Continuous glucose monitoring, Aged, 2. Zero hunger, Blood Glucose Self-Monitoring, Geriatrics - Radboud University Medical Center, Blood Glucose/analysis, Middle Aged, 16. Peace & justice, name=Medical Laboratory Technology, Type 2/complications, Hypoglycemia, Circadian Rhythm, 3. Good health, Diabetes and Metabolism, Sleep tracking, Diabetes Mellitus, Type 1, Nocturnal hypoglycemia, Diabetes Mellitus, Type 2, Hypoglycemia/blood, Circadian Rhythm/physiology, Female, name=Endocrinology, Sleep, Insulin/administration & dosage

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38386436
https://research.vumc.nl/en/publications/3107f60c-0c49-4a57-a1d4-902aa62aa834
https://pure.amsterdamumc.nl/en/publications/1654a8ba-6570-4d38-aaf1-d762a11794a0
https://doi.org/10.1089/dia.2023.0522
https://hdl.handle.net/2066/308693
https://repository.ubn.ru.nl//bitstream/handle/2066/308693/308693.pdf
https://kclpure.kcl.ac.uk/ws/files/294990671/Martine-Edith_et_al._Clock_based_nocturnal_vs_asleep_hypoglycemia.pdf

Predictive factors of hypoglycemia in type 2 diabetes: a prospective study using machine learning

Autoren: Shabestari, M. Mehrabbeik, A. Barbieri, S. et al.

Quelle: Sci Rep
Scientific Reports, Vol 15, Iss 1, Pp 1-13 (2025)
Scientific reports, vol. 15, no. 1, pp. 18143

Schlagwörter: SHAP, Science, Type 2 diabetes mellitus, Machine learning, Medicine, Humans, Diabetes Mellitus, Type 2/complications, Diabetes Mellitus, Type 2/blood, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemia/etiology, Hypoglycemia/epidemiology, Hypoglycemia/diagnosis, Hypoglycemia/blood, Machine Learning, Female, Male, Middle Aged, Prospective Studies, Risk Factors, Aged, Blood Glucose/analysis, Adult, Hypoglycemic Agents/adverse effects, Hypoglycemic Agents/therapeutic use, Blood Glucose Self-Monitoring, Glycated Hemoglobin/analysis, Insulin/therapeutic use, Insulin/adverse effects, Hypoglycemia prediction, Article

Dateibeschreibung: application/pdf

Zugangs-URL: https://doaj.org/article/bc217115928642bdaace4bc547fe64d1
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E928AF7544EC5
https://serval.unil.ch/notice/serval:BIB_E928AF7544EC
https://serval.unil.ch/resource/serval:BIB_E928AF7544EC.P001/REF.pdf

Adherencija bolesnika pri liječenju šećerne bolesti u obiteljskoj medicini u Republici Hrvatskoj prema istraživanju EUROASPIRE V

Autoren: KOVAČEC, LOVORKA CEROVEČKI, VENIJA KERMC, INO et al.

Quelle: Liječnički vjesnik, Vol 147, Iss 1-2, Pp 22-29 (2025)
Liječnički vjesnik
CODEN LIVJA5
Volume 147
Issue 1-2

Schlagwörter: Medicine (General), HYPOGLYCEMIC AGENTS – therapeutic use, CROATIA – epidemiology, medication adherence – statistics and numerical data, MEDICATION ADHERENCE – statistics and numerical data, ANKETE I UPITNICI, DIABETES MELLITUS, TYPE 2 – drug therapy, epidemiology, R5-920, PRIDRŽAVANJE LIJEČENJA – statistički podatci, hypoglycemic agents – therapeutic use, OBITELJSKA MEDICINA – statistički podatci, PATIENT COMPLIANCE – statistics and numerical data, patient compliance – statistics and numerical data, Diabetes mellitus, type 2 – drug therapy, epidemiology, ŠEĆERNA BOLEST TIPA 2 – epidemiologija, farmakoterapija, life style, SURADLJIVOST BOLESNIKA – statistički podatci, family practice – statistics and numerical data, SURVEYS AND QUESTIONNAIRES, FAMILY PRACTICE – statistics and numerical data, HIPOGLIKEMICI – terapijska uporaba, surveys and questionnaires, LIFE STYLE, NAČIN ŽIVOTA, Croatia – epidemiology, HRVATSKA – epidemiologija

Dateibeschreibung: application/pdf

Zugangs-URL: https://doaj.org/article/b296a8d5f8414e9e825511f3a6bd80e2
https://urn.nsk.hr/urn:nbn:hr:105:187749
https://doi.org/10.26800/lv-147-1-2-2
https://hrcak.srce.hr/328779
https://doi.org/10.26800/LV-147-1-2-2
https://hrcak.srce.hr/328779
https://doi.org/10.26800/lv-147-1-2-2

Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial

Autoren: Steven E. Kahn John E. Deanfield Ole Kleist Jeppesen et al.

Quelle: Diabetes Care
SELECT Trial Investigators 2024, 'Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial', Diabetes Care, vol. 47, no. 8, pp. 1350-1359. https://doi.org/10.2337/dc24-0491

Schlagwörter: Male, Blood Glucose, Glycated Hemoglobin, 0301 basic medicine, 2. Zero hunger, Obesity/drug therapy, Glucagon-Like Peptides/therapeutic use, Glucagon-Like Peptides, Hypoglycemic Agents/therapeutic use, Middle Aged, Overweight, 16. Peace & justice, Glycated Hemoglobin/metabolism, 3. Good health, 03 medical and health sciences, Blood Glucose/drug effects, 0302 clinical medicine, Double-Blind Method, Overweight/drug therapy, Humans, Hypoglycemic Agents, Original Article, Female, Obesity, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38907683
https://diabetesjournals.org/care/article/47/8/1350/156833/Effect-of-Semaglutide-on-Regression-and
https://doi.org/10.2337/dc24-0491
https://pergamos.lib.uoa.gr/uoa/dl/object/3483281
https://ruj.uj.edu.pl/handle/item/419239
https://pure.au.dk/portal/en/publications/c84c35ad-0b91-4f55-8e8a-481a235fce09
http://www.scopus.com/inward/record.url?scp=85199815375&partnerID=8YFLogxK
https://doi.org/10.2337/dc24-0491

The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer

Autoren: Ibrahim, Shahad Sabaawi Ibrahim, Raghad Sabaawi Arabi, Batoul et al.

Quelle: Cancer Metastasis Rev

Schlagwörter: 2. Zero hunger, 0301 basic medicine, 0303 health sciences, Review, Obesity, Hypoglycemic Agents/pharmacology [MeSH], Cancer, Glucagon-Like Peptide-1 Receptor/agonists [MeSH], Semaglutide, Humans [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Animals [MeSH], Obesity/drug therapy [MeSH], Neoplasms/metabolism [MeSH], Diabetes, Obesity/metabolism [MeSH], Neoplasms/pathology [MeSH], Neoplasms/drug therapy [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Diabetes Mellitus, Type 2/metabolism [MeSH], GLP1RA, Ozempic, 3. Good health, 03 medical and health sciences, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists, Neoplasms, Humans, Animals, Hypoglycemic Agents

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38801466
https://repository.publisso.de/resource/frl:6501526

Safety of Empagliflozin: An Individual Participant-Level Data Meta-Analysis from Four Large Trials

Autoren: Christoph Wanner Hristo Iliev Nathalia Duarte et al.

Quelle: Adv Ther

Schlagwörter: Male, Heart Failure, ddc:610, Middle Aged, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Randomized Controlled Trials as Topic [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Adverse drug event, Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Original Research, SGLT2 inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Adverse drug reaction, Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Drug safety, Cardiovascular Diseases [MeSH], Heart Failure [MeSH], Middle Aged [MeSH], Renal Insufficiency, Chronic [MeSH], Glucosides/therapeutic use [MeSH], Empagliflozin, Glucosides, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Humans, Hypoglycemic Agents, Female, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Randomized Controlled Trials as Topic

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38771475
https://repository.publisso.de/resource/frl:6508947
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-398088
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39808
https://doi.org/10.1007/s12325-024-02879-w
https://opus.bibliothek.uni-wuerzburg.de/files/39808/12325_2024_Article_2879.pdf

Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics

Autoren: Zoé Henry Sylvie Villar Fimbel Nathalie Bendelac et al.

Weitere Verfasser: Zoé Henry Sylvie Villar Fimbel Nathalie Bendelac et al.

Quelle: Diabetes, Obesity and Metabolism. 26:557-566

Schlagwörter: Adult, Male, Blood Glucose, automated insulin delivery, Adolescent, [SDV]Life Sciences [q-bio], Glucose/therapeutic use, Human/therapeutic use, Hypoglycemic Agents/therapeutic use, Insulin Infusion Systems, Insulin, Regular, Human, Blood Glucose Self-Monitoring/methods, Humans, Insulin, Hypoglycemic Agents, real-world evidence, Insulin/therapeutic use, Regular, Retrospective Studies, Glycated Hemoglobin, Diabetes Mellitus, diabetes, Blood Glucose Self-Monitoring, Blood Glucose/analysis, 3. Good health, [SDV] Life Sciences [q-bio], Diabetes Mellitus, Type 1, Glucose, time in range, Type 1/drug therapy, Female, closed-loop system, Humans, Male, Female, Adolescent, Adult, Follow-Up Studies, Retrospective Studies, Blood Glucose/analysis, diabetes, *Diabetes Mellitus, Type 1/drug therapy, Hypoglycemic Agents/therapeutic use, Insulin Infusion Systems, Glycated Hemoglobin, automated insulin delivery, closed-loop system, real-world evidence, time in range, *Insulin/therapeutic use, Blood Glucose Self-Monitoring/methods, Glucose/therapeutic use, Insulin, Regular, Human/therapeutic use, Follow-Up Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37905353
https://hal.science/hal-04661064v1
https://doi.org/10.1111/dom.15344

Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitus

Autoren: Low, Chan Yew Gan, Wei Ling Lai, Su Jeat et al.

Quelle: J Nanobiotechnology
Journal of Nanobiotechnology, Vol 23, Iss 1, Pp 1-25 (2025)
Low, C Y, Gan, W L, Lai, S J, Tam, R S-M, Tan, J F, Dietl, S, Chuah, L H, Voelcker, N & Bakhtiar, A 2025, ' Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitus ', Journal of Nanobiotechnology, vol. 23, no. 1, 16 . https://doi.org/10.1186/s12951-024-03062-7

Schlagwörter: Oral, Blood Glucose, Diabetes Mellitus, Type 2/drug therapy, Oral insulin, Administration, Oral, Hypoglycemic Agents/therapeutic use, Review, Clinical, Blood Glucose/drug effects, Drug Delivery Systems, Type 2 diabetes mellitus, Diabetes Mellitus, Drug Delivery Systems/methods, Medical technology, Humans, Insulin, Hypoglycemic Agents, Animals, R855-855.5, Preclinical, Type 2/drug therapy, Diabetes Mellitus, Type 2, Administration, Insulin/administration & dosage, Advance drug delivery, TP248.13-248.65, Biotechnology

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39815320
https://doaj.org/article/ed2b8a6d82d54c719b59f5d89f53fc08
https://curis.ku.dk/ws/files/422452217/s12951_024_03062_7.pdf